Platelet Aggregation Inhibitors Concept

subject area of

• 14 Antithrombotic treatment of cerebrovascular disease  Academic Article
• 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Academic Article
• CYP2C19 Genetic Testing Should Not Be Done in All Patients Treated With Clopidogrel Who Are Undergoing Percutaneous Coronary Intervention  Academic Article
• Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Guidelines, Update 2014  Academic Article
• d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy  Academic Article
• A Barbourin-albumin Fusion Protein that Is Slowly Cleared In Vivo Retains the Ability to Inhibit Platelet Aggregation In Vitro  Academic Article
• A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction  Academic Article
• A National Survey of Canadian Practice Patterns of Warfarin After Anterior Wall Myocardial Infarction in the Current Era of Dual Antiplatelet Therapy  Academic Article
• A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation  Academic Article
• A Nurse-coordinated Model of Care versus Usual Care for Stage 3/4 Chronic Kidney Disease in the Community  Academic Article
• A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score  Academic Article
• A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation  Academic Article
• A population‐based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors  Academic Article
• A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes  Academic Article
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)  Academic Article
• A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin  Academic Article
• A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery  Academic Article
• ADP-stimulated fibrinogen binding is necessary for some of the inositol phospholipid changes found in ADP-stimulated platelets  Academic Article
• AIDA STEMI: no benefit for intracoronary abciximab  Academic Article
• Abciximab in Acute Ischemic Stroke  Academic Article
• Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors  Academic Article
• Active metabolite concentration of clopidogrel in patients taking different doses of aspirin: results of the interaction trial  Academic Article
• Acute Profound Thrombocytopenia Associated with Eptifibatide Therapy  Academic Article
• Acute management of bleeding in patients on novel oral anticoagulants  Academic Article
• Acute reversal of anticoagulant-induced bleeding complications.  Academic Article
• Adding aspirin to clopidogrel after TIA and ischemic stroke: Benefits do not match risks  Academic Article
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation  Academic Article
• Advances in Antithrombotic Therapy: Novel Agents  Academic Article
• Advances in Understanding “High on-Treatment Platelet Reactivity”  Academic Article
• After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding  Academic Article
• Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry  Academic Article
• An optimum prophylactic dose of prasugrel monotherapy may safely and effectively prevent the development of experimental thrombotic strokes  Academic Article
• Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation  Academic Article
• Angina (unstable).  Academic Article
• Angina (unstable).  Academic Article
• Angina (unstable).  Academic Article
• Animal Models of Thrombosis From Zebrafish to Nonhuman Primates  Academic Article
• Anti-platelet therapy and the anaesthesiologist: controversies and unresolved clinical dilemmas continue  Academic Article
• Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?  Academic Article
• Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers  Academic Article
• Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers  Academic Article
• Anticoagulation/platelet inhibition for atrial fibrillation  Academic Article
• Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.  Academic Article
• Antiplatelet Agents in Acute Coronary Syndromes  Academic Article
• Antiplatelet Drugs  Academic Article
• Antiplatelet Drugs  Academic Article
• Antiplatelet Effect of Active Components Derived from Chinese Herbal Medicine  Academic Article
• Antiplatelet Therapy and Cardiac Surgery: Review of Recent Evidence and Clinical Implications  Academic Article
• Antiplatelet Therapy and Coronary Artery Bypass Grafting: Analysis of Current Evidence With a Focus on Acute Coronary Syndrome  Academic Article
• Antiplatelet Therapy and Vascular-Access Patency  Academic Article
• Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke  Academic Article
• Antiplatelet Therapy in Cerebral Small Vessel Disease  Academic Article
• Antiplatelet Therapy versus Anticoagulation after Surgical Bioprosthetic Aortic Valve Replacement: A Systematic Review and Meta-Analysis  Academic Article
• Antiplatelet drugs  Academic Article
• Antiplatelet therapy and coronary artery bypass grafting  Academic Article
• Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysis  Academic Article
• Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial  Academic Article
• Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Academic Article
• Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Academic Article
• Antiplatelet therapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Key messages for clinical practice  Academic Article
• Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials  Academic Article
• Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease  Academic Article
• Antiplatelet therapy in prevention of cardio- and venous thromboembolic events  Academic Article
• Antiplatelet therapy in the management of atherothrombosis: recent clinical advances  Academic Article
• Antiplatelet use in patients with essential thrombocythemia: A survey of opinion and Canadian practice  Academic Article
• Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair  Academic Article
• Antithrombotic Agents  Academic Article
• Antithrombotic Agents in Coronary Artery Disease  Academic Article
• Antithrombotic Agents in Coronary Artery Disease  Academic Article
• Antithrombotic Therapy for Cerebrovascular Disorders  Academic Article
• Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes  Academic Article
• Antithrombotic Therapy in Neonates and Children  Academic Article
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Academic Article
• Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Academic Article
• Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts Following Percutaneous Transluminal Coronary Angioplasty  Academic Article
• Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making  Academic Article
• Antithrombotic Treatment at Onset of Stroke with Atrial Fibrillation, Functional Outcome, and Fatality: A Systematic Review and Meta-Analysis  Academic Article
• Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses  Academic Article
• Antithrombotic actions of statins.  Academic Article
• Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding  Academic Article
• Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves  Academic Article
• Antithrombotic therapy in aortic diseases: A narrative review  Academic Article
• Antithrombotic therapy in atrial fibrillation.  Academic Article
• Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis  Academic Article
• Antithrombotics in stable peripheral artery disease  Academic Article
• Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome  Academic Article
• Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease  Academic Article
• Approche pratique à la prescription des antiplaquettaires chez les patients atteints de syndromes coronariens  Academic Article
• Appropriate Assessment of the Functional Consequences of Platelet Cyclooxygenase-1 Inhibition by Aspirin in vivo  Academic Article
• Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.  Academic Article
• Are all P2Y12 equally effective in vein graft angioplasty? A report from the UK database  Academic Article
• Aspirin  Academic Article
• Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty  Academic Article
• Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke  Academic Article
• Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.  Academic Article
• Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects  Academic Article
• Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects.  Academic Article
• Aspirin for Acute Coronary Syndromes: Have We Learned the Correct Dose Yet?  Academic Article
• Aspirin for Dual Prevention of Venous and Arterial Thrombosis  Academic Article
• Aspirin for Preventing Venous Thromboembolism  Academic Article
• Aspirin for Prevention and Treatment of Cardiovascular Disease  Academic Article
• Aspirin for preventing venous thromboembolism.  Academic Article
• Aspirin for preventing venous thromboembolism.  Academic Article
• Aspirin for the Prevention of Recurrent Venous Thromboembolism  Academic Article
• Aspirin in Patients Undergoing Noncardiac Surgery  Academic Article
• Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery  Academic Article
• Aspirin in secondary prevention of recurrent venous thromboembolism  Academic Article
• Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty  Academic Article
• Aspirin plus clopidogrel was not linked to risk for cancer compared with aspirin alone or no antiplatelets  Academic Article
• Aspirin resistance  Academic Article
• Aspirin resistance: Table 1  Academic Article
• Aspirin resistance: does it exist and is it an important clinical problem?  Academic Article
• Aspirin response variability after major orthopedic surgery  Academic Article
• Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding  Academic Article
• Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: Insights from the Global Registry of Acute Coronary Events  Academic Article
• Atorvastatin Delays Murine Platelet Activation In Vivo Even in the Absence of Endothelial NO Synthase  Academic Article
• Atrial Fibrillation and PCI — Do We Still Need Aspirin?  Academic Article
• Atrial Fibrillation in Patients with Cryptogenic Stroke  Academic Article
• Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke?  Academic Article
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.  Academic Article
• BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase  Academic Article
• Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups  Academic Article
• Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range  Academic Article
• Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study  Academic Article
• Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia  Academic Article
• Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome  Academic Article
• Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin  Academic Article
• Beyond Heparin and Aspirin  Academic Article
• Bivalirudin  Academic Article
• Bleeding Complications in Patients with Acute Coronary Syndromes: Are They Important and How Can We Prevent Them?  Academic Article
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin  Academic Article
• Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis  Academic Article
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis  Academic Article
• CAPRIE trial.  Academic Article
• COMPASS for Vascular Surgeons  Academic Article
• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up  Academic Article
• Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter  Academic Article
• Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease  Academic Article
• Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy  Academic Article
• Cangrelor: a new CHAMPION for percutaneous coronary intervention  Academic Article
• Cervical artery dissection: Pathology, epidemiology and management  Academic Article
• Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial  Academic Article
• Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source  Academic Article
• Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry  Academic Article
• Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial  Academic Article
• Clinical Studies: Evidence for Intervention with Specific Antiplatelet Drugs in Arterial Thromboembolism  Academic Article
• Clinical decisions. Management of stable coronary disease.  Academic Article
• Clinical potential of antithrombotic drugs in coronary syndromes  Academic Article
• Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)  Academic Article
• Clopidogrel Resistance  Academic Article
• Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events  Academic Article
• Clopidogrel and percutaneous coronary intervention  Academic Article
• Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes  Academic Article
• Clopidogrel plus aspirin in atrial fibrillation.  Academic Article
• Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis  Academic Article
• Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial  Academic Article
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients  Academic Article
• Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease  Academic Article
• Combination Therapy to Prevent Cardiovascular Disease  Academic Article
• Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?  Academic Article
• Combined Antiplatelet Therapy in Atrial Fibrillation:  Academic Article
• Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease  Academic Article
• Combined antiplatelet and anticoagulant therapy: clinical benefits and risks  Conference Paper
• Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?  Academic Article
• Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations  Academic Article
• Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (αIIb/β3) receptor-directed platelet inhibition  Academic Article
• Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition  Academic Article
• Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis  Academic Article
• Comparison of High-Dose With Low-Dose Aspirin in Patients With Mechanical Heart Valve Replacement Treated With Oral Anticoagulant  Academic Article
• Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular Diseases  Academic Article
• Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non–Q-wave myocardial infarction undergoing percutaneous coronary intervention  Academic Article
• Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial  Academic Article
• Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models  Academic Article
• Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II  Academic Article
• Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial  Academic Article
• Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?  Academic Article
• Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting  Academic Article
• Contemporary use of guideline‐based higher potency P2Y12 receptor inhibitor therapy in patients with moderate‐to‐high risk non‐ST‐segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross‐sectional study  Academic Article
• Coronary artery stenting in patients treated by clopidogrel without aspirin  Academic Article
• Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease  Academic Article
• Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND)  Academic Article
• Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: A long-term analysis based on the CURE trial  Academic Article
• Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the cure trial  Academic Article
• Current Evidence for Genetic Testing in Clopidogrel-Treated Patients Undergoing Coronary Stenting  Academic Article
• Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin  Academic Article
• Decreasing Mortality With Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: The Mayo Clinic Experience From 1991 Through 1997  Conference Paper
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients  Academic Article
• Delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI): Protocol for a pragmatic, cluster-randomized controlled trial  Academic Article
• Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy  Academic Article
• Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy  Academic Article
• Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis  Academic Article
• Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor  Academic Article
• Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet‐mediated events during thrombus formation  Academic Article
• Differences in Ischemic and Hemorrhagic Recurrence Rates among Race-Ethnic Groups in the PRoFESS Secondary Stroke Prevention Trial  Academic Article
• Different perspective on ASA use.  Academic Article
• Discordance Between Physicians' Estimation of Patient Cardiovascular Risk and Use of Evidence-Based Medical Therapy  Academic Article
• Do Patients with Acute Myocardial Infarction Benefit from Treatment with Clopidogrel?  Academic Article
• Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?  Academic Article
• Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes  Academic Article
• Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial  Academic Article
• Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention  Academic Article
• Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions  Academic Article
• Dual Antiplatelet Therapy After Percutaneous Coronary Intervention  Academic Article
• Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence  Academic Article
• Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society  Academic Article
• Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline  Academic Article
• Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events  Academic Article
• Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances.  Academic Article
• Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease  Academic Article
• Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study  Academic Article
• Early Recovery and Functional Outcome are Related with Causal Stroke Subtype: Data from the Tinzaparin in Acute Ischemic Stroke Trial  Academic Article
• Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes  Academic Article
• Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non–ST-elevation ACS  Academic Article
• Economic issues in glycoprotein IIb/IIIa receptor therapy  Academic Article
• Effect of Addition of Clopidogrel to Aspirin on Stroke Incidence: Meta-Analysis of Randomized Trials  Academic Article
• Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation  Academic Article
• Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation  Academic Article
• Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke  Academic Article
• Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model  Academic Article
• Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma  Academic Article
• Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention  Academic Article
• Effect of PCI on Quality of Life in Patients with Stable Coronary Disease  Academic Article
• Effect of R and S Enantiomers of Naproxen on Aggregation and Thromboxane Production in Human Platelets  Academic Article
• Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation  Academic Article
• Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study  Academic Article
• Effect of aspirin in vascular surgery in patients from a randomized clinical trial (POISE-2)  Academic Article
• Effect of desmopressin on hematoma expansion in antiplatelet-associated intracerebral hemorrhage: A systematic review and meta-analysis  Academic Article
• Effectiveness and safety of abciximab after failed thrombolytic therapy  Academic Article
• Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials  Academic Article
• Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study  Academic Article
• Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes  Academic Article
• Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation  Academic Article
• Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial  Academic Article
• Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?  Academic Article
• Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study  Academic Article
• Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study  Academic Article
• Effects of ibrutinib on in vitro platelet aggregation in blood samples from healthy donors and donors with platelet dysfunction  Academic Article
• Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial  Academic Article
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study  Academic Article
• Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension  Academic Article
• Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI  Academic Article
• Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment  Academic Article
• Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines  Academic Article
• Efficacy and Safety of Warfarin VS. Antiplatelet Therapy in Patients with Systolic Heart Failure and Sinus Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  Academic Article
• Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial  Academic Article
• Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials  Academic Article
• Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use  Academic Article
• Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease  Academic Article
• Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD  Academic Article
• Efficacy of Antiplatelet Therapy in Secondary Prevention Following Lacunar Stroke  Academic Article
• Eicosapentaenoic Acid Interferes with U46619-Stimulated Formation of Inositol Phosphates in Washed Rabbit Platelets  Academic Article
• Embolization of the deep cervical collaterals—a unique endovascular approach to prevent repeated posterior fossa strokes refractory to medical therapy  Academic Article
• Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial  Academic Article
• Ethanol enhances the inhibitory effect of an oral GPIIb/IIIa antagonist on human platelet function  Academic Article
• Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials  Academic Article
• Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: In-hospital and six-month outcomes  Academic Article
• Executive Summary  Academic Article
• Expert Consensus Document on the Use of Antiplatelet Agents The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology  Academic Article
• Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials  Academic Article
• Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial  Academic Article
• Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards  Academic Article
• Fifty years of research on antithrombotic therapy: Achievements and disappointments  Academic Article
• Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis  Academic Article
• Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy  Academic Article
• From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE)  Academic Article
• G-Protein–Coupled Receptors as Signaling Targets for Antiplatelet Therapy  Academic Article
• Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non???ST-Segment Elevation Acute Coronary Syndromes  Academic Article
• Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH  Academic Article
• Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week  Academic Article
• Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.  Academic Article
• HFSA Guidelines for Management of Patients With Heart Failure Caused by Left Ventricular Systolic Dysfunction—Pharmacological Approaches  Academic Article
• HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heparin-induced thrombocytopenia and the anesthesiologist.  Academic Article
• Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes  Academic Article
• High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source  Academic Article
• How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch  Academic Article
• How can the results of the COMPASS trial benefit patients with coronary or peripheral artery disease in Poland?  Academic Article
• How good is aspirin for patients with acute brain ischaemia?  Academic Article
• IIb or not IIb: When, how, and which GP IIb/IIIa inhibitor?  Academic Article
• ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction  Academic Article
• ISTH guidelines for antithrombotic treatment in COVID‐19  Academic Article
• Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease  Academic Article
• Impact of Insulin Receptor Substrate‐1 rs956115 and CYP2C19 rs4244285 Genotypes on Clinical Outcome of Patients Undergoing Percutaneous Coronary Intervention  Academic Article
• Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban  Academic Article
• Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel  Academic Article
• Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE])  Academic Article
• Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry  Academic Article
• Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta‐analysis  Academic Article
• Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial  Academic Article
• Impact of provincial and national implementation strategies on P2Y12 inhibitor utilization for acute coronary syndrome in the elderly: an interrupted time series analysis from 2008 to 2018  Academic Article
• In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y  Academic Article
• In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets  Academic Article
• In patients receiving DAPT after coronary stents, the PRECISE-DAPT score predicted bleeding moderately well  Academic Article
• In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.  Academic Article
• Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy  Academic Article
• Increased Uptake of Guideline-Recommended Oral Antiplatelet Therapy: Insights from the Canadian Acute Coronary Syndrome Reflective  Academic Article
• Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children  Conference Paper
• Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel  Academic Article
• Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation  Academic Article
• Independent predictors of stroke in patients with atrial fibrillation: A systematic review  Academic Article
• Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention  Academic Article
• Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women  Academic Article
• Inhibition of Microsurgical Thrombosis by the Platelet Glycoprotein IIb/IIIa Antagonist SR121566A  Academic Article
• Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes.  Academic Article
• Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction  Academic Article
• Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia  Academic Article
• Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome  Academic Article
• Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial  Academic Article
• Intensity and Quality of Warfarin Anticoagulation in Chinese Patients  Academic Article
• Interaction of low molecular weight heparin with ketorolac  Academic Article
• International Perspectives on the Impact of the COVID-19 Pandemic on Adherence to Prescribed Dual Antiplatelet Therapy: A Window Into Acute Cardiovascular Care  Academic Article
• International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis  Academic Article
• Interruption of Warfarin Anticoagulation for Dental Surgery: Response  Academic Article
• Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial  Academic Article
• Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments  Academic Article
• Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy  Academic Article
• Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.  Academic Article
• Is Daily Low-Dose Aspirin Safe to Take Following Laparoscopic Roux-en-Y Gastric Bypass for Obesity Surgery?  Academic Article
• Is it safe to use a proton pump inhibitor with clopidogrel?  Academic Article
• Is there a benefit of low-dose aspirin in assisted reproduction?  Academic Article
• Is there a role for laboratory testing to identify patients at risk of aspirin treatment failure?  Academic Article
• Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy  Academic Article
• Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion.  Academic Article
• Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation  Academic Article
• Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016–2017  Academic Article
• Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin  Academic Article
• Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke  Academic Article
• Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction  Academic Article
• Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction  Academic Article
• Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation  Academic Article
• Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation  Academic Article
• Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation  Academic Article
• Long-term outcomes after acute myocardial infarction in countries with different socioeconomic environments: an international prospective cohort study  Academic Article
• Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI  Academic Article
• Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement  Academic Article
• Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy  Academic Article
• Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.  Academic Article
• Low rates of preventive practices in patients with peripheral vascular disease.  Academic Article
• Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism  Academic Article
• Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial  Academic Article
• Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials  Academic Article
• Low-dose rivaroxaban plus aspirin for the prevention of cardiovascular events: an evaluation of COMPASS  Academic Article
• Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial  Academic Article
• Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.  Academic Article
• Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease  Academic Article
• Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin  Academic Article
• Management of Patients on Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Peri-Endoscopic Period: A Clinical Practice Guideline Dissemination Tool  Academic Article
• Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy  Academic Article
• Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures  Academic Article
• Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures  Academic Article
• Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT)  Academic Article
• Meeting report ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007  Academic Article
• Meta-analysis: colonoscopic post-polypectomy bleeding in patients on continued clopidogrel therapy  Academic Article
• Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions  Academic Article
• Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease  Academic Article
• Mortality benefit in the COMPASS trial: is it related to superior statistical power or better efficacy and safety?  Academic Article
• Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W  Academic Article
• Multiple daily doses of acetyl‐salicylic acid (ASA) overcome reduced platelet response to once‐daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial  Academic Article
• Myocardial Infarction in Neonates: A Review of an Entity with Significant Morbidity and Mortality  Academic Article
• Myocardial Infarction, Peptic Ulcer and Acetylsalicylic Acid: Of Good and Evil  Academic Article
• Myocardial injury after noncardiac surgery  Academic Article
• Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable  Academic Article
• New Antithrombotic Agents  Academic Article
• New Antithrombotic Drugs  Academic Article
• New Antithrombotic Drugs  Academic Article
• New Antithrombotics  Academic Article
• New anticoagulant strategies.  Academic Article
• New anticoagulants in atrial fibrillation management  Conference Paper
• New antithrombotic agents—insights from clinical trials  Academic Article
• Non-ST segment elevation acute coronary syndromes: A simplified risk-oriented algorithm  Academic Article
• Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial  Academic Article
• Off-pump coronary artery bypass grafting attenuates postoperative bleeding associated with preoperative clopidogrel administration.  Conference Paper
• Once versus twice daily aspirin after coronary bypass surgery: a randomized trial  Academic Article
• Optimal Medical Therapy with or without PCI for Stable Coronary Disease  Academic Article
• Optimal Medical Therapy, Lifestyle Intervention, and Secondary Prevention Strategies for Cardiovascular Event Reduction in Ischemic Heart Disease  Academic Article
• Optimizing the Use of Abciximab and Intracoronary Stents in Patients with Acute ST Elevation Myocardial Infarction  Academic Article
• Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis  Academic Article
• Oral Anticoagulant Therapy in Patients with Coronary Artery Disease  Academic Article
• Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease  Academic Article
• Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation  Academic Article
• Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease  Academic Article
• Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives  Academic Article
• Oral anticoagulants and non-cardioembolic stroke prevention  Academic Article
• Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease  Academic Article
• Oral anticoagulants in patients with coronary artery disease  Academic Article
• Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks  Academic Article
• Oral antiplatelet therapy.  Academic Article
• Oral factor Xa inhibitors and risk of subdural hematoma  Academic Article
• Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation  Academic Article
• Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF  Academic Article
• Overexpression of the Multidrug Resistance Protein-4 Transporter in Patients Undergoing Coronary Artery Bypass Graft Surgery  Academic Article
• Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction  Academic Article
• P2Y12 receptor inhibitor resistance and coronary artery disease  Academic Article
• P2x-purinoceptors of myenteric neurones from the guinea-pig ileum and their unusual pharmacological properties  Academic Article
• PPI co-therapy did not adversely affect outcomes in clopidogrel users  Academic Article
• Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro  Academic Article
• Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways  Academic Article
• Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence  Academic Article
• Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline  Academic Article
• Patients with Peripheral Artery Disease in the COMPASS Trial  Academic Article
• Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in Canada  Academic Article
• Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury  Academic Article
• Perioperative Management of Antiplatelet Therapy in Patients With a Coronary Stent Who Need Noncardiac Surgery  Academic Article
• Perioperative Management of Antithrombotic Therapy  Academic Article
• Perioperative Management of Antithrombotic Therapy  Academic Article
• Perioperative Management of Patients Having Noncardiac Surgery Who Are Receiving Anticoagulant or Antiplatelet Therapy: An Evidence-Based but Practical Approach  Academic Article
• Perioperative Management of Patients Receiving Anticoagulant or Antiplatelet Therapy: A Clinician-Oriented and Practical Approach  Academic Article
• Perioperative Treatment With Aspirin or Clonidine and Risk of Acute Kidney Injury—Reply  Academic Article
• Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines  Academic Article
• Perioperative management of antithrombotic therapy: a case-based narrative review  Academic Article
• Perioperative management of patients who are receiving antiplatelet therapy: a case-based, evidence-informed approach  Academic Article
• Peripheral arterial disease.  Academic Article
• Peripheral arterial disease.  Academic Article
• Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications  Academic Article
• Periphere arterielle Verschlusskrankheit (PAVK)  Academic Article
• Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH  Academic Article
• Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH  Academic Article
• Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis  Academic Article
• Pharmacogenetics of Stroke  Academic Article
• Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran  Academic Article
• Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research  Academic Article
• Phase III Study of N,N-Diethyl-2-[4-(Phenylmethyl) Phenoxy]Ethanamine (BMS-217380-01) Combined With Doxorubicin Versus Doxorubicin Alone in Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19  Academic Article
• Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future  Academic Article
• Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry  Academic Article
• Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function  Academic Article
• Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects  Academic Article
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.  Academic Article
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects.  Academic Article
• Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment  Academic Article
• Point-of-care testing for assessment of adequacy of oral antiplatelet therapy in patients with cardiovascular disease  Academic Article
• Polymerizing Fibrin Decreases the Polyphosphoinositides in Chymotrypsin-Treated Human Platelets  Academic Article
• Polypill with or without Aspirin in Persons without Cardiovascular Disease  Academic Article
• Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study  Academic Article
• Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial  Academic Article
• Pre-Hospital Cardiac Arrest in Acute Coronary Syndromes: Insights from the Global Registry of Acute Coronary Events and the Canadian Registry of Acute Coronary Events  Academic Article
• Preadmission Antiplatelet Use and Associated Outcomes and Costs Among ICU Patients With Intracranial Hemorrhage  Academic Article
• Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A])  Academic Article
• Predictors of Mortality in Patients With Lacunar Stroke in the Secondary Prevention of Small Subcortical Strokes Trial  Academic Article
• Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF  Academic Article
• Preventing Thromboembolism in Patients with Prosthetic Heart Valves  Academic Article
• Preventing stroke in patients with atrial fibrillation: Current treatments and new concepts  Academic Article
• Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes.  Academic Article
• Prevention and Management of Urgent/Emergent Limb Ischemia  Academic Article
• Prevention of Vascular Events in Patients with Atrial Fibrillation:  Academic Article
• Prevention of activation of blood coagulation during acute coronary ischemic syndromes beyond aspirin and heparin  Academic Article
• Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone  Academic Article
• Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness  Academic Article
• Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial  Academic Article
• Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation  Academic Article
• Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke  Academic Article
• Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Academic Article
• Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”  Academic Article
• Proton Pump Inhibitors and Clopidogrel – Hazardous Drug Interaction or Hazardous Interpretation of Data?  Academic Article
• Proton pump inhibitor and clopidogrel interaction: The case for watchful waiting  Academic Article
• Prévention des complications vasculaires après ischémie cérébrale d'origine artérielle. Étude ESPRIT: anticoagulation modérée, association aspirine-dipyridamole ou aspirine seule ?  Academic Article
• Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm  Academic Article
• Randomised trials of secondary prevention programmes in coronary heart disease: systematic review  Academic Article
• Randomized Trials to Assess the Long-term Effects of Therapies on Angiographic End Points  Academic Article
• Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation  Academic Article
• Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non–ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: Results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial  Academic Article
• Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study  Academic Article
• Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)  Academic Article
• Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events  Academic Article
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Academic Article
• Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention  Academic Article
• Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: An international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs placebo and clonidine vs placebo in patients undergoing noncardiac surgery  Academic Article
• Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)  Academic Article
• Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study  Academic Article
• Re: Anticoagulation and Antiplatelet Therapy in Urological Practice: ICUD/AUA Review Paper: D. J. Culkin, E. J. Exaire, D. Green, M. S. Soloway, A. J. Gross, M. R. Desai, J. R. White and D. J. Lightner J Urol 2014; 192: 1026-1034  Academic Article
• Recent Safety Concerns With Proton Pump Inhibitors  Academic Article
• Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation  Academic Article
• Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin  Academic Article
• Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure  Academic Article
• Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin  Academic Article
• Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates  Academic Article
• Renal function and outcomes in acute coronary syndrome: impact of clopidogrel  Academic Article
• Reply  Academic Article
• Resource Use and Costs of Treatment With Anticoagulation and Antiplatelet Agents: Results of the WATCH Trial Economic Evaluation  Academic Article
• Response  Academic Article
• Response by Bagai et al to Letter Regarding Article, “Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention”  Academic Article
• Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies  Academic Article
• Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management  Academic Article
• Reversal of the anti‐platelet effects of aspirin and clopidogrel  Academic Article
• Reversing Anticoagulant Therapy  Academic Article
• Review of aspirin and clopidogrel resistance in peripheral arterial disease  Academic Article
• Review: After PCI with DESs, long- and standard-term DAPT increase some adverse outcomes vs short-term DAPT  Academic Article
• Risk factor documentation in elective and emergency vascular surgical admissions  Academic Article
• Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation  Academic Article
• Risk of recurrent venous thromboembolism according to baseline risk factor profiles  Academic Article
• Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk  Academic Article
• Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials  Academic Article
• Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis  Academic Article
• Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial  Academic Article
• Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease  Academic Article
• Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease  Academic Article
• Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization  Academic Article
• Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios  Academic Article
• Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization  Academic Article
• Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline  Academic Article
• Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source  Academic Article
• Rivaroxaban for the prevention of major adverse cardiovascular events in patients with coronary or peripheral artery disease  Academic Article
• Rivaroxaban in Peripheral Artery Disease after Revascularization  Academic Article
• Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism  Academic Article
• Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial  Academic Article
• Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition  Academic Article
• Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial  Academic Article
• Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial  Academic Article
• Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial  Academic Article
• Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease  Academic Article
• Rivaroxaban with or without aspirin for prevention of cardiovascular disease  Academic Article
• Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial  Academic Article
• Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial  Academic Article
• Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease  Academic Article
• Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents  Academic Article
• Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole artery model.  Academic Article
• Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction  Academic Article
• Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.  Academic Article
• Routine vs Selective Invasive Strategies in Acute Coronary Syndromes  Academic Article
• Safer anticoagulant therapy after heart valve replacement  Academic Article
• Safety and efficacy of ginkgo (Ginkgo biloba) during pregnancy and lactation.  Academic Article
• Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin  Academic Article
• Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS)  Academic Article
• Secondary prevention of venous thromboembolism  Academic Article
• Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD  Academic Article
• Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention  Academic Article
• Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials  Academic Article
• Simultaneous measurement of adenosine triphosphate release and aggregation potentiates human platelet aggregation responses for some subjects, including persons with Quebec platelet disorder  Academic Article
• Single or Dual Antiplatelet Treatment after TAVI  Academic Article
• Site of Action for the Inhibition by Gold Sodium Thiomalate of Rabbit Platelet Activation  Academic Article
• Standardized Bleeding Definitions for Cardiovascular Clinical Trials  Academic Article
• State of the Art-A Journey through the World of Antithrombotic Therapy  Academic Article
• State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism  Academic Article
• Stroke Prevention in Nonvalvular Atrial Fibrillation  Academic Article
• Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program  Academic Article
• Structure and function of a perioperative anticoagulation management clinic  Academic Article
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease  Academic Article
• Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale  Academic Article
• Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes  Academic Article
• Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes  Academic Article
• Tetrandrine differentially inhibits aggregation and ATP-release of rat platelets.  Academic Article
• The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy  Academic Article
• The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease  Academic Article
• The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial  Academic Article
• The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes  Academic Article
• The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients  Academic Article
• The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population  Academic Article
• The Fat-Mass and Obesity-Associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women  Academic Article
• The Interaction Between Proton Pump Inhibitors and Clopidogrel and Upper Gastrointestinal Bleeding  Academic Article
• The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial  Academic Article
• The Perioperative Management of Antithrombotic Therapy  Academic Article
• The Pursuit of Clinically Relevant Measures of Platelet Function After Antiplatelet Drug Therapy⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.  Academic Article
• The Relative Efficacy and Safety of Clopidogrel in Women and Men  Academic Article
• The Secondary Prevention of Small Subcortical Strokes (SPS3) Study  Academic Article
• The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines  Academic Article
• The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary  Academic Article
• The Use of Platelet Function Assays May Help to Determine Appropriate Antiplatelet Treatment Options in a Patient With Recurrent Stroke on Baby Aspirin  Academic Article
• The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics  Academic Article
• The aspirin controversy in primary prevention  Academic Article
• The beginning of the end of warfarin?  Academic Article
• The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problem  Academic Article
• The cost implications of a polypill for primary prevention in the TIPS-3 trial  Academic Article
• The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study.  Academic Article
• The effect of antiplatelet therapy on survival and cardiac allograft vasculopathy following heart transplantation: A systematic review and meta‐analysis  Academic Article
• The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies  Academic Article
• The effects of oral anticoagulants in patients with peripheral arterial disease: Rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials  Academic Article
• The evolving treatment of peripheral arterial disease: preventing ischaemic events in the post-COMPASS era  Academic Article
• The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians  Academic Article
• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study  Academic Article
• The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect  Academic Article
• The polypill: from concept and evidence to implementation  Academic Article
• The reemergence of aspirin for the prevention of venous thromboembolism.  Academic Article
• The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study  Academic Article
• The role of platelets and platelet inhibition in acute myocardial infarction  Academic Article
• The significance of new onset atrial fibrillation complicating acute myocardial infarction  Academic Article
• The use of glycoprotein IIb/IIIa receptor inhibitors in unstable angina.  Academic Article
• Therapeutic strategies for thrombosis: new targets and approaches  Academic Article
• There seems to be a low risk of experiencing postoperative bleeding in patients undergoing dental extractions or minor oral surgery who continue using antiplatelet therapy  Academic Article
• Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors  Academic Article
• Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials  Academic Article
• Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.  Academic Article
• Thromboprophylaxis practice patterns in hip fracture surgery patients: experience in Perth, Western Australia  Academic Article
• Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis  Academic Article
• Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study  Academic Article
• Timing of Antiplatelet Resumption After Intracerebral Hemorrhage: A Sophie’s Choice  Academic Article
• Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin  Academic Article
• To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections  Academic Article
• Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: Which form of aspirin is the fastest to inhibit platelet aggregation in emergency department patients with non-ST segment elevation myocardial infarction?  Academic Article
• Treating Patients With Acute Coronary Syndromes With Aggressive Antiplatelet Therapy (from the Global Registry of Acute Coronary Events)  Academic Article
• Treatment of Acute Coronary Syndromes  Academic Article
• Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experience  Academic Article
• Unstable Angina and Non–ST-Elevation Myocardial Infarction  Academic Article
• Unstable angina.  Academic Article
• Unstable angina.  Academic Article
• Use of Alternative Medicines by Patients with OA that Adversely Interact with Commonly Prescribed Medications  Academic Article
• Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes  Academic Article
• Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes  Academic Article
• Use of Warfarin in People with Low Glomerular Filtration Rate or on Dialysis  Academic Article
• Use of genetic data to guide therapy in arterial disease  Academic Article
• Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey  Academic Article
• Use of the Pipeline Shield in the Posterior Circulation with Single Antiplatelet Therapy: A Case of Delayed In-stent Thrombosis  Academic Article
• Validity of Composite Outcomes in Meta-Analyses of Stroke Prevention Trials: The Case of Aspirin  Academic Article
• Valproate‐mediated disturbances of hemostasis  Academic Article
• Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy  Academic Article
• Vascular access and antiplatelet therapies: does one influence the other?  Academic Article
• Vascular viewpoint  Academic Article
• Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial  Academic Article
• Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm  Academic Article
• Warfarin in Heart Failure  Academic Article
• What do the results of the PRoFESS trial teach us?  Academic Article
• When guidelines collide  Academic Article
• Which Risk Factors Are More Associated With Ischemic Stroke Than Intracerebral Hemorrhage in Patients With Atrial Fibrillation?  Academic Article
• Will prasugrel supersede clopidogrel for acute coronary syndromes?  Academic Article
• XIX congress of the European Society of Cardiology August 24-28, 1997, Stockholm, Sweden.  Conference Paper
• Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both  Academic Article
• [Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].  Academic Article